Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4

10.1038/s41467-023-40829-2

Saved in:

Bibliographic Details
Main Authors:	Kim, YN, Park, B, Kim, JW, Kim, BG, Kim, SW, Kim, HS, Choi, CH, Lim, MC, YL Ngoi, N, SP Tan, D, Lee, JY
Other Authors:	MEDICINE
Format:	Article
Published:	Springer Science and Business Media LLC 2023
Subjects:	Humans Female Bevacizumab Antibodies, Monoclonal, Humanized Carcinoma, Ovarian Epithelial Ovarian Neoplasms
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/245266
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-245266
record_format	dspace
spelling	sg-nus-scholar.10635-2452662024-04-17T09:35:14Z Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 Kim, YN Park, B Kim, JW Kim, BG Kim, SW Kim, HS Choi, CH Lim, MC YL Ngoi, N SP Tan, D Lee, JY MEDICINE Humans Female Bevacizumab Antibodies, Monoclonal, Humanized Carcinoma, Ovarian Epithelial Ovarian Neoplasms 10.1038/s41467-023-40829-2 Nature Communications 14 1 5476- 2023-10-13T03:28:25Z 2023-10-13T03:28:25Z 2023-12-01 2023-10-12T12:27:08Z Article Kim, YN, Park, B, Kim, JW, Kim, BG, Kim, SW, Kim, HS, Choi, CH, Lim, MC, YL Ngoi, N, SP Tan, D, Lee, JY (2023-12-01). Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4. Nature Communications 14 (1) : 5476-. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-023-40829-2 2041-1723 https://scholarbank.nus.edu.sg/handle/10635/245266 Springer Science and Business Media LLC Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Humans Female Bevacizumab Antibodies, Monoclonal, Humanized Carcinoma, Ovarian Epithelial Ovarian Neoplasms
spellingShingle	Humans Female Bevacizumab Antibodies, Monoclonal, Humanized Carcinoma, Ovarian Epithelial Ovarian Neoplasms Kim, YN Park, B Kim, JW Kim, BG Kim, SW Kim, HS Choi, CH Lim, MC YL Ngoi, N SP Tan, D Lee, JY Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
description	10.1038/s41467-023-40829-2
author2	MEDICINE
author_facet	MEDICINE Kim, YN Park, B Kim, JW Kim, BG Kim, SW Kim, HS Choi, CH Lim, MC YL Ngoi, N SP Tan, D Lee, JY
format	Article
author	Kim, YN Park, B Kim, JW Kim, BG Kim, SW Kim, HS Choi, CH Lim, MC YL Ngoi, N SP Tan, D Lee, JY
author_sort	Kim, YN
title	Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
title_short	Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
title_full	Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
title_fullStr	Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
title_full_unstemmed	Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
title_sort	triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with brca wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase ii study opeb-01/apgot-ov4
publisher	Springer Science and Business Media LLC
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/245266
_version_	1800915948850380800

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4

Similar Items